Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
CSF Proteomics Test for ALS?
24 November 2004. Surveying the protein profile of a tissue or body fluid by traditional methods—separating proteins by 2D gels and then analyzing the spots by mass spectrometry—has not proven a very efficient way to detect changes in protein levels in neurodegenerative diseases, according to Jonas Bergquist and his colleagues at Uppsala University in Sweden.

In an article published 12 November 2004 in the journal Proteomics, Bergquist and colleagues report that an alternative approach can distinguish protein profiles of the cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS) from those of control subjects. The method uses liquid chromatography (LC) and capillary electrophoresis to separate proteins and Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS) to detect protein peaks. The data is then analyzed to detect peptide patterns.

The traditional methods have not yielded any insights into proteome changes of the CSF in ALS, but first author Margareta Ramstrom and colleagues took note of the fact that LC-FT-ICR MS had proven at least as accurate in a number of studies of different animal tissues and fluids. As a first trial run of the method, and their pattern recognition algorithm, the authors showed that they could detect different concentrations (1.4 and 0.14 micromolar) of horse myoglobin added to human CSF to mimic upregulation of a protein.

Ramstrom and colleagues then evaluated chromatograms from 12 ALS patients and 10 control subjects. Perhaps because of the low number of samples, the researchers were unable to identify a particular protein whose CSF levels were altered in the disease relative to control. However, their pattern recognition algorithm was able to correctly classify four of five blinded samples as being from ALS patients, and the fifth was believed to be misclassified because of a known anomaly in the patient's spinal cord.

Regarding this technique, which might be useful both for diagnosis and etiologic research, the authors write that "An advantage of the method is the low sample consumption required for the analysis; a volume corresponding to only 16 microliters of CSF is needed for one LC-experiment. Also, the mass chromatogram is collected during approximately 1 [hour] and the total time for sample preparation prior to MS is another hour, except for the overnight incubation.”—Hakon Heimer.

Reference:
Ramstrom M, Ivonin I, Johansson A, Askmark H, Markides KE, Zubarev R, Hakansson P, Aquilonius SM, Bergquist J. Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry. Proteomics. 2004 Nov 12; [Epub ahead of print] Ramstrom M, Ivonin I, Johansson A, Askmark H, Markides KE, Zubarev R, Hakansson P, Aquilonius SM, Bergquist J. Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry. Proteomics. 2004 Nov 12 [Epub ahead of print] Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad